The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome-Reference-Cited by-同舟云学术

The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome

Published:2019-08-14 Issue:5 Volume:54 Page:1901401
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

D'Alto Michele^ORCID,Constantine Andrew^ORCID,Balint Olga Hajnalka,Romeo Emanuele,Argiento Paola,Ablonczy Laszlo,Skoro-Sajer Nika,Giannakoulas George,Dimopoulos Konstantinos

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference17 articles.

1. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification

2. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: Rationale, design, and first results

3. Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience

4. Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977–2012

5. Declining incidence and prevalence of Eisenmenger syndrome in the developed world: a triumph of modern medicine

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?;International Journal of Cardiology Congenital Heart Disease;2024-09

2. Update on Eisenmenger syndrome – Review of pathophysiology and recent progress in risk assessment and management;International Journal of Cardiology Congenital Heart Disease;2024-09

3. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

4. Pulmonary arterial hypertension related to congenital heart disease with a left-to-right shunt: phenotypic spectrum and approach to management;Frontiers in Cardiovascular Medicine;2024-05-09

5. Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure;Heart Failure Clinics;2024-04